Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyzed Asymmetric Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.